The Antidote: Inside the World of New Pharma
| Author | : | |
| Rating | : | 4.66 (970 Votes) |
| Asin | : | 1451655665 |
| Format Type | : | paperback |
| Number of Pages | : | 448 Pages |
| Publish Date | : | 2017-03-26 |
| Language | : | English |
DESCRIPTION:
Barry Werth is an award-winning journalist and the acclaimed author of six books. He has taught journalism and nonfiction writing at Smith, Mount Holyoke, and Boston University. . His landmark first book, The Billion-Dollar Molecule, recounts the founding and early struggles of Vertex. Werth’s articles have appeared in The New Yorker, The New York Times Magazine, and GQ, among others
This is the Moneyball of the pharma world, the story of one drug company’s quest to transform the pharmaceutical industry and a deeply revealing look into a world where breakneck capitalism meets life-saving medicine.IN THE ANTIDOTE, Barry Werth draws upon unprecedented inside reporting spanning more than two decades to provide a groundbreaking closeup of the upstart pharmaceutical company Vertex and the ferocious but indispensable world of Big Pharma that it inhabits.In 1989, the charismatic Joshua Boger left Merck, then America’s most admired business, to found a drug company that would challen
Create the 21st century biopharmaceutical company. Joshua Boger, founding scientist and president, along with a group of young scientists, set out in a garage to overtake the big drug companies. --Mary Whaley . The author returns to Vertex to learn what it takes to succeed in science and business and sees that 22 years later and at about four times the anticipated cost, Vertex is now set to achieve Boger’s initial goals: “Make better drugs, faster. Become Merck, only better.” Werth seeks to discover what Boger’s vision has become and considers if it is
"The tribulations and triumph of drug development" according to Ash Jogalekar. As a biomedical scientist I really enjoyed this book. It is the sequel to the author's previous volume "The Billion Dollar Molecule". Both books provide a fly-on-the-wall account of Vertex Pharmaceuticals, an innovative biopharmaceutical company that brought two breakthrough medicines - one for hepatitis C and the other for cystic fibrosis - to market two years ago. Both these drugs were the first of their kind and have given thousands of patients a new lease on life. From a broader perspective however, the author's goal is to shed light both on the immensely challenging proce. A great read educating the public on what it takes for a new drug to come to market Geese As a retired "Merckie" in R&D, I found Barry Werth's insider views incredibly interesting and educational. More non scientists should read these two books. Most people haven't the faintest idea what it takes to discover, collabarate, scaleup, purify, clinically test, manufacture and market a new drug or vaccine. Not to mention publication and patent and naming issues. Great books.. Epic Journey of Scientists trying to save the world Clergyboy This book is amazing because I never thought a corporation can have so many souls dancing inside, let alone a Pharma company. I want to say that I exaggerated only a little to compare this book's story to the 10 year Trojan War.What really touched me are the stories of individuals. The Bogers who "bore the torch" in the early days of doing great science and exploring the frontiers, the successors who financed and commercialized the founders' vision, the Wall Street analysts wanting to milk the new Pharmas like they did with the old, the patient advocates who wanted Vertex to r